AKT1 and neoplasm: Finally, mechanistic analysis confirmed that CB reduced MYH9 levels via downregulation of PI3K/AKT/c-Myc/P53/miR-133a-3p, which increased GSK3β expression to antagonize β-catenin-activated tumor stemness and EMT signals.